Bioethics News

Funding: Donor Drugs

Funding: Donor Drugs

May 4, 2016

(Nature) – In the past decade venture philanthropy has experienced a resurgence, with many foundations focused on new therapies. But the attributes that make this type of funding so effective can also stir up controversy or raise ethical questions. Philanthropic foundations are not accountable to the public, and some critics question whether wealthy benefactors have too much sway in medicine.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.